Freedom Capital Markets initiates Veracyte stock with Buy rating, $45 target
PositiveFinancial Markets

Freedom Capital Markets has initiated coverage of Veracyte with a Buy rating and a target price of $45. This is significant as it reflects confidence in Veracyte's growth potential and market position, which could attract more investors and positively impact the stock's performance.
— Curated by the World Pulse Now AI Editorial System